<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04435093</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0150</org_study_id>
    <secondary_id>2020-A01752-37</secondary_id>
    <nct_id>NCT04435093</nct_id>
  </id_info>
  <brief_title>Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.</brief_title>
  <acronym>MFM-Play pilot</acronym>
  <official_title>Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Motor Function Measure (MFM) is a functional rating scale consisting of 32 items
      assessing motor functional abilities in a person with neuromuscular disease.

      By exploring the potential of digital technologies applied to MFM, for each item completion
      we want to create digital animations containing different playful and informative scenarios.
      This digital evolution aims to standardize assessment on the therapist's side, but also to
      improve acceptance of scale and patient participation.

      Despite the modification of the MFM completion by digital animation, the study hypothesis is
      that the metrological qualities of the scale are retained.

      Through the MFM-Play pilot study, the objective is to test 5 items of the MFM-Play scale
      before carrying out a validation study of the total MFM-Play.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MFM scores item 18 to 22</measure>
    <time_frame>Day 1</time_frame>
    <description>Level of agreement between the scores obtained during the classic mode and during the MFM-Play mode, completed by two different therapists.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <arm_group>
    <arm_group_label>MFM completion</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MFM-Play</intervention_name>
    <description>Neuromuscular patients will complete five items of the MFM (items 18 to 22) either conventionally or using the MFM-Play with 2 different therapists, on the same day. The order of the MFM type completion will be determined by randomization. Both therapists will rate items 18 to 22 blindly.</description>
    <arm_group_label>MFM completion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will involve children with a neuromuscular disease, aged 6 to 11 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Girls and boys with a neuromuscular disease

          -  Aged 6 to 11 years old

          -  With parental assent

        Exclusion Criteria:

          -  Patients participating to a therapeutic trial

          -  Patients without compartmental capacities to participate normally to the MFM.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Vincent-Genod</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique Vincent-Genod</last_name>
    <phone>04 72 12 95 04</phone>
    <phone_ext>+33</phone_ext>
    <email>dominique.vincent-genod@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pascal Rippert</last_name>
    <phone>04 27 85 63 08</phone>
    <phone_ext>+33</phone_ext>
    <email>pascal.rippert@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Dominique Vincent-Genod</last_name>
      <phone>04 72 12 95 04</phone>
      <phone_ext>+33</phone_ext>
      <email>dominique.vincent-genod@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pascal Rippert</last_name>
      <phone>04 27 85 63 08</phone>
      <phone_ext>+33</phone_ext>
      <email>pascal.rippert@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Dominique Vincent-Genod</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Veronique BOURG, MD</last_name>
      <phone>04.76.76.75.75</phone>
      <phone_ext>+33</phone_ext>
      <email>vbourg@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Veronique BOURG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Saint Etienne</name>
      <address>
        <city>Saint-Ã‰tienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Vincent GAUTHERON, MD</last_name>
      <phone>04.77.82.87.29</phone>
      <phone_ext>+33</phone_ext>
      <email>vincent.gautheron@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent GAUTHERON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>June 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2020</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

